Develo Raises $14M for AI Pediatric Health OS

Develo, a startup aiming to modernize pediatric healthcare administration, has successfully closed a $14 million funding round. The investment, spearheaded by Blueprint Equity, with significant contributions from Villain Capital, Z21 Ventures, and Bienville Capital, signals strong market confidence in Develo's vision. The infusion of capital will fuel the company's expansion of its AI-native operating system, designed to replace fragmented and outdated electronic medical record (EMR) systems prevalent in pediatric practices.

The pediatric healthcare sector, serving over 450 million annual visits in the U.S., has long grappled with inefficient workflows. Many clinics operate using a disparate collection of software for patient charting, billing, appointment scheduling, and patient communication. This fragmentation leads to substantial administrative overhead and clinician burnout. Develo's approach tackles this head-on by creating a unified, AI-first platform specifically tailored for the unique needs of pediatric care, a segment often underserved by generalized healthcare IT solutions.

Founded in 2022 by Dr. Aaron Sin, MD, and CTO Han Ke, Develo is building what it terms the first AI-native operating system for pediatrics. This integrated system aims to streamline clinical operations, enhance patient-provider communication, and optimize revenue cycles. The platform's architecture is built from the ground up with artificial intelligence at its core, incorporating features like an AI scribe, automated charge capture, and intelligent reporting, differentiating it from legacy systems that are now adding AI as an afterthought.

The funding round attracted notable industry veterans, underscoring the perceived value of Develo's solution. Key angel investors include Chris Sullens, CEO of CentralReach; Chris Barton, Executive Chair of Community CareLink and former Cerner executive; and Paul Black, former CEO of Allscripts. Their participation highlights the industry's recognition of the challenges Develo is addressing and the potential of its AI-driven approach.

“Pediatric practices are burdened by a patchwork of disconnected tools, leading to significant administrative strain and physician dissatisfaction,” stated Dr. Aaron Sin, Develo CEO and co-founder. “Our AI-native operating system is purpose-built to address these specific pain points, offering a unified solution that enhances efficiency and improves the care experience, rather than relying on bolt-on AI features for legacy systems.”

This strategic investment positions Develo to accelerate its research and development efforts and bolster its customer success operations. The company's focus on a specialized AI-native platform for pediatrics enters a healthtech market where AI adoption is rapidly increasing, driven by the need to reduce costs and combat clinician burnout. Develo's foundational AI approach offers a compelling alternative to incremental updates on older software, aiming to redefine operational standards within pediatric medicine.